IMUX earnings: a negative outcome, -7.6%

On November 3, 2022, IMMUNIC, INC. reached its earnings. The result was a negative outcome, and the stock moved -7.6% in the window around the event. It had already run -50.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.